Connect with us

Business Partnerships

Canadian Cannabis Provider, Cronos Group Moves into US Cannabis Market with Four Acquisitions



Canadian Cannabis Provider, Cronos Group Moves into US Cannabis Market with Four Acquisitions

It has been recently revealed that Canadian cannabis provider, Cronos Group has officially entered the US cannabis market by acquiring four subsidiaries belonging to the Redwood Holding Group and others reports Grizzle.

With a sum of $300 million paid for this endeavor, the acquisition supposedly includes Lord Jones, a brand devoted to CBD infusions, which is currently awaiting regulatory approval for shelving. That said, the brands moving from Redwood to Cronos will remain as is (i.e. name-wise), as consumers know the brand for not only its products but also its name.

According to the CEO of Cronos Group, Mike Gorenstein, the goal is to,

“preserve the integrity of all [Robert Rosenheck] and [Cindy Capobianco] created, while also learning from them and leveraging Cronos Group’s resources to capitalize on the significant demand for consumer products derived from hemp.”

In addition to Redwood and Lord Jones, Cronos also supposedly acquired a fermentation and manufacturing facility of 84,000 sq. feet, which will be used to create new forms of cultured cannabinoids – a venture between Cronos and Ginkgo Bioworks Inc.

Hemp Industry Daily also reported on this matter, and emphasized on another partnership between North American tobacco firm, Altria Group and Cronos, which was described by Gorenstein as unlocking more opportunities for Cronos.

In particular, it was shared that:

“Through the Altria partnership, we do have access to over 200,000 retail stores across the U.S [and] access to networks of farmers that can convert from growing tobacco to growing hemp.”

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.